Antibody-Drug Conjugate (ADC) ndi mtundu watsopano wa mankhwala a biotechnology omwe amaphatikiza mankhwala ang'onoang'ono a molekyulu kuti aloze ma antibodies/chidutswa cha antibody ndi olumikizira.
Gawo la 63 la SOT linatha bwino lomwe, ndipo chisangalalo cha IPHASE-US sichitha! Msonkhano Wapachaka wa 63 wa American Society of Toxicology unachitika bwino kuyambira pa Marichi 10-14, 2024, mu
Mau oyamba a Chiwindi Microsomes ndi tiziduswa tating'ono ta vesicular tochokera ku endoplasmic reticulum ndipo timapezeka m'ma cell a chiwindi (hepatocytes). Amatenga gawo lofunikira muzambiri zosiyanasiyana
Posachedwapa, IPHASE, molumikizana ndi Perelman School of Medicine ku University of Pennsylvania, adalemba nawo nkhani m'magazini ya Antibody Therapeutics (IF=4.56) yotchedwa "Development of a
IntroductionT cell ndi gawo lofunikira kwambiri la chitetezo chamthupi, limagwira ntchito yofunika kwambiri pozindikira ndi kuthana ndi tizilombo toyambitsa matenda. Kachitidwe ka T cell activation ndizovuta, multi-step mechanis
Mau Oyambirira a Ma cell B ndi Kufunika KwawoMunjira yodabwitsa ya chitetezo cha mthupi cha munthu, ma B cell amagwira ntchito yofunika kwambiri. Monga mtundu wa maselo oyera a m'magazi, B ma cell ndi ofunikira ku adaptive immune re
Zogulitsa za kampaniyo bwino kwambiri, tagula ndi kugwirizana nthawi zambiri, mtengo wabwino ndi khalidwe lotsimikizika, mwachidule, iyi ndi kampani yodalirika!